Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study With Oxaliplatin + 5-FU + Ceuximab and Radiotherapy for the Treatment of Non-resectable, Locally Advanced But Not Metastatic Cancer of Oesophagus or the Cardia.

NCT02636088 is registered in ClinicalTrials.gov with Gabriella Alexandersson von Döbeln as lead sponsor.

NCT NCT02636088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02636088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study With Oxaliplatin + 5-FU + Ceuximab and Radiotherapy for the Treatment of Non-resectable, Locally Advanced But Not Metastatic Cancer of Oesophagus or the Cardia.
Lead sponsor
Gabriella Alexandersson von Döbeln
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2011
Completion date
January 31, 2019
Enrollment
51 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasm